World’s first RSV vaccine approved by FDA — breakthrough 60 years in the making
"Our focus now is to ensure eligible older adults in the US can access the vaccine as quickly as possible," said Tony Wood, the chief scientific officer at GSK.
Top tags
Today most read articles
Article
Similar articles